22 November 2017
News and Views
Links and Services
January's issue of the Inflammatory Bowel Diseases identifies factors associated with durable response to infliximab in Crohn's disease.
Infliximab has been used for over a decade worldwide.
Less is known about the natural hist
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors